This website uses cookies to enhance the user experience.
||
L

LUZMON MEDICAL AS995 871 238

Limited company
Oscars gate 42 0258 OSLO, Norge

LUZMON MEDICAL AS

Operating
Forskning innen helse.

Organization

CEO
Chairman of the board
Years since formation
16 years
since Aug 30, 2010
Type
Limited company
VAT registered
Yes
Number of employees
0

Ownership

Number of shares and share classes
2,000
1 share class
Total number of shareholders
1
company
Belongs to group of

Financials

Total operating income 2025
104,128
NOK
Annual total result 2025
-6,570,125
NOK
Last update: Jul 27, 2026

Management

Management / administration

NameRoleShares
Managing Director/CEO
100 %
indirectly

Board

NameRoleShares
Chairman
100 %
indirectly
Board Member-

Others

NameRoleShares
H
HKW NORGE MOMENTUM AS
Auditor-
E
ECONPARTNER AS
Accountant-

Top 10 individual shareholders

NameRoleShares
Managing Director/CEO, Chairman
100 %
indirectly
Last update: Jul 2, 2026

Ownership

Company shareholders

NameShare classTotal number of sharesShare
L
LUZMON HOLDING AS
Ordinary shares
2,000
100 %

Shares owned by the LUZMON MEDICAL AS

NameShare classTotal number of sharesShare
O
OPTISAN AS
Ordinary shares
2,362
5.41 %
V
VILJE BIONICS AS
Ordinary shares
3,255
5.28 %
Last update: Jun 2, 2025

Group structure

  • Total operating income 2025: NOK 0
    Operating profit 2025: NOK -117,541
    Employees: 0

Financials

in NOK

Summary

Year20252024202320222021
Total operating income
104,128
1,607,017
0
105,000
0
Annual Total Result
-6,570,125
72,750
-36,718,848
98,589,809
-31,355,917
Total assets
0
76,728,232
97,160,199
210,844,074
71,622,579
Total liabilities
0
1,810,969
2,315,686
47,280,713
6,649,027
Total equity
0
74,917,263
94,844,513
163,563,361
64,973,552

P&L

Year20252024202320222021
Total operating income
104,128
1,607,017
0
105,000
0
Total operating costs
7,676,752
7,314,695
43,973,588
-63,611,920
31,351,201
Operating result
-7,572,624
-5,707,678
-43,973,588
63,716,920
-31,351,201
Financial income/costs
1,002,498
5,780,428
7,254,740
34,872,889
-4,716
Profit before tax
-6,570,125
72,750
-36,718,848
98,589,809
-31,355,917
Total tax & extraordinary income/cost
0
0
0
0
0
Annual Total Result
-6,570,125
72,750
-36,718,848
98,589,809
-31,355,917

Balance overview

Year20252024202320222021
Total fixed assets
0
38,784,635
14,204,695
45,504,658
66,353,954
Total current assets
0
37,943,597
82,955,504
165,339,415
5,268,625
Total assets
0
76,728,232
97,160,199
210,844,074
71,622,579
Short term debt
0
1,810,969
2,315,686
15,513,932
6,174,027
Long term debt
0
0
0
31,766,780
475,000
Total liabilities
0
1,810,969
2,315,686
47,280,713
6,649,027
Contributed capital
0
64,973,552
64,973,552
64,973,552
64,973,552
Retained earnings
0
9,943,711
29,870,961
98,589,809
0
Total equity
0
74,917,263
94,844,513
163,563,361
64,973,552
Total equity and liabilities
0
76,728,232
97,160,199
210,844,074
71,622,579

Classification

21st company classification
BETA
Individual SMB enterprise
Type of organization
Limited company
Classification of institutional sector
INNL
Domestic sectors
A_IKKE-FIN
Non-financial corporations
2100
Private non-financial incorporated enterprises